ALEXIS HOFSTETTER: Open Payments
NPI 1831974492 · MADISON, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 16 payments from 11 companies in 2025. Trend: 2023 $204 · 2024 $1,272 · 2025 $408
Food & beverage: $408
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $144 |
| Vanda Pharmaceuticals Inc. | 2 | $56 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
| Sage Therapeutics, LLC | 2 | $43 |
| Tris Pharma Inc | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Alkermes, Inc. | 1 | $16 |
Products named: Auvelity, UZEDY, ZURZUVAE, HETLIOZ, FANAPT, Dyanavel XR, INGREZZA, VRAYLAR.
Industry payments across WI — which companies pay providers there.
